Physician profile
Anthony Khim
NPI 1295736940
$18,563.37
in general payments reported to CMS, 2019-2025
60 companies · $6,994 in 2025
The $6,994 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,862 · 2020: $1,839 · 2021: $1,155 · 2022: $1,287 · 2023: $2,544 · 2024: $2,882 · 2025: $6,994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,524 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $1,877 · Education: $18.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,524.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $1,877.29 |
| Education | $18.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avyxa Pharma, LLC | $3,838.94 | 2025 | |
| Janssen Biotech, INC. | $1,433.48 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Boston Scientific Corporation | $1,226.83 | 2019-2025 | Axonics, Rezum Generator, Ams 700 |
| Pfizer INC. | $1,197.29 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $985.54 | 2023-2025 | Provenge |
| Sumitomo Pharma America, INC. | $846.89 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $792.88 | 2019-2025 | |
| Axonics, INC. | $782.26 | 2020-2024 | Axonics |
| Astellas Pharma US INC | $720.28 | 2019-2025 | Myrbetriq, Xtandi |
| Endo Pharmaceuticals INC. | $545.20 | 2019-2022 | |
| Urogen Pharma, INC. | $513.45 | 2020-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $470.18 | 2022-2025 | Lynparza, Keytruda, Welireg |
| Procept Biorobotics Corporation | $386.34 | 2022-2025 | Aquabeam Robotic System |
| Bayer Healthcare Pharmaceuticals INC. | $366.76 | 2019-2025 | |
| Coloplast Corp | $339.17 | 2024-2025 |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $334.53 | 2022-2024 | Trelstar, Tlando |
| Tolmar, INC. | $327.04 | 2023-2025 | Eligard, Jatenzo |
| Allergan, INC. | $313.59 | 2019-2022 | |
| Calyxo, INC. | $292.22 | 2024-2025 | Cvac Aspiration System |
| Astrazeneca Pharmaceuticals LP | $278.59 | 2020-2025 | Lynparza |
| Medtronic USA, INC. | $208.27 | 2020 | |
| Antares Pharma, INC. | $207.27 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Accord Healthcare, INC. | $176.27 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $167.81 | 2023 | Pylarify |
| Myovant Sciences INC. | $156.51 | 2022 | |
| Ferring Pharmaceuticals INC. | $135.26 | 2024-2025 | Adstiladrin |
| Clarus Therapeutics INC. | $125.00 | 2021 | |
| Endo USA, INC. | $103.86 | 2025 | Xiaflex, Aveed |
| Caris Mpi, INC. | $103.46 | 2025 | Mi Cancer Seek |
| Janssen Scientific Affairs, LLC | $102.19 | 2019-2020 | |
| Amgen INC. | $100.86 | 2019-2022 | |
| Aytu Biopharma, INC. | $81.03 | 2019 | |
| Bard Access Systems, INC. | $69.23 | 2019 | |
| Olympus America INC. | $62.04 | 2019-2025 | Itind System, Shockpulse |
| Novartis Pharmaceuticals Corporation | $61.30 | 2025 | |
| Travere Therapeutics, INC. | $58.84 | 2020-2021 | |
| Halozyme INC | $58.63 | 2023 | |
| Blue Earth Diagnostics | $41.01 | 2021-2022 | |
| Ambu INC. | $37.90 | 2021 | |
| Profound Medical Corp. | $35.81 | 2023 | Tulsa-Pro |
| C. R. Bard, INC. & Subsidiaries | $35.13 | 2020 | |
| Angiodynamics, INC. | $34.82 | 2023 | Nanoknife |
| Rochester Medical Corporation | $31.82 | 2019 | |
| Telix Pharmaceuticals | $31.60 | 2025 | Illuccix |
| Convatec INC. | $31.13 | 2023-2025 | |
| Urovant Sciences INC | $30.12 | 2021 | |
| Alnylam Pharmaceuticals INC. | $29.85 | 2023 | Oxlumo |
| Azurity Pharmaceuticals, INC. | $28.67 | 2025 | Azmiro |
| Conmed Corporation | $26.76 | 2025 | Conmed Specimen Retrieval, Airseal |
| Inspire Medical Systems, INC. | $24.34 | 2025 | Inspire |
| Acerus Pharmaceuticals Corporation | $24.20 | 2021 | |
| Becton, Dickinson and Company | $23.12 | 2023 | Bard Urinary Drainage Bag |
| 180 Medical, INC. | $19.92 | 2021 | |
| Hollister Incorporated | $19.31 | 2023 | Vapro |
| Photocure INC | $18.28 | 2024 | Cysview |
| Medtronic, INC. | $15.81 | 2022 | |
| Foundation Medicine, INC. | $15.09 | 2022 | |
| Valencia Technologies Corporation | $14.22 | 2025 | Ecoin Device Kit |
| Covidien LP | $12.92 | 2019 | |
| Laborie Medical Technologies Corp. | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Khim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.